The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
1,000 jobs Number of planned job creations
Announcement Date
6 January 2025
Employment effect (start)
6 January 2025
Foreseen end date
31 December 2025
Description
Multinational pharmaceutical company MSD is to create 1000 jobs in Ireland over the next 12 months. The jobs were announced as part of an acquisition by MSD of the WuXi Vaccines manufacturing facility in Dundalk, Co Louth.
MSD Ireland said that including the acquisition, it will be adding 1,000 new jobs across its eight locations in counties Carlow, Cork, Dublin, Louth, Meath and Tipperary. Some 150 new jobs will be at the newly acquired Dundalk site where 200 people are currently employed.
MSD currently employs 3,000 people in Ireland across its various sites.
Eurofound (2025), MSD, Merger/Acquisition in Ireland, factsheet number 202290, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/202290.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
